Darifenacin
Composition
Contains Darifenacin Hydrobromide, typically 7.5 mg or 15 mg per extended-release tablet.
Indications
Used to treat overactive bladder symptoms such as urgency, frequency, and urge incontinence.
Side effects
Dry mouth, constipation, headache, dizziness, blurred vision.
Precautions
Use cautiously in patients with liver impairment, constipation, or those taking CYP3A4 inhibitors.
Contraindications
Urinary retention, gastric retention, uncontrolled narrow-angle glaucoma, hypersensitivity to Darifenacin.
Dosage and administration
Start with 7.5 mg once daily; may increase to 15 mg if tolerated.
Countries
Available Forms
Extended-release tablets.